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http:WHAT THIS PAPER ADDS
Reliability parameters indicate the robustness of a measurement instrument, and measurement error pertains
to its precision. To date, both have hardly been studied for the VascuQol. This study demonstrates that teste
retest reliability and measurement error of the Dutch version of the VascuQol are excellent, which strengthens
all ﬁndings based on this instrument.Objectives: Although the Vascular Quality of Life Questionnaire (VascuQol) is a widely used instrument to assess
quality of life in patients with peripheral arterial disease (PAD), data on its reliability are scarce and its
measurement error is unknown. The aim of this study was to determine testeretest reliability and measurement
error of the Dutch version of the VascuQol in patients with intermittent claudication (IC).
Methods: Patients with intermittent claudication due to PAD presenting between October 2013 and April 2014
completed the VascuQol twice, with a 1 week interval. Testeretest reliability was expressed as the intraclass
correlation coefﬁcient (ICC) with 95% conﬁdence interval (CI), and measurement error as a standard error of
measurement (SEM).
Results: Sixty-one patients completed two VascuQol questionnaires sufﬁciently. The ICC for the VascuQol
sumscore was 0.91 (95% CI 0.86e0.95). The ICC for the different VascuQol domains ranged between 0.77 (95% CI
0.64e0.86) and 0.87 (95% CI 0.79e0.92). The SEM of the sumscore was 0.34 and ranged between 0.44 and 0.76
for the different VascuQol domains.
Conclusions: The testeretest reliability of the Dutch version of the VascuQol is excellent, both for the sumscore
and for its different domains. The VascuQol has a measurement error that is sufﬁciently small to allow detection
of clinically relevant changes.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Intermittent claudication (IC) due to peripheral arterial
disease (PAD) is a chronic condition. Exercise induced pain
in the legs results in limited walking capacity for patients,
which affects their health related quality of life (HRQL).1 The
disease-speciﬁc vascular quality of life questionnaire (Vas-
cuQol) was designed to measure HRQL in patients with
symptomatic PAD, and has been translated into several
languages including Dutch. The VascuQol is one of the most
frequently used HRQL instruments in PAD research.2 In aresponding author. Department of Vascular Surgery, Academic
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disease-speciﬁc HRQL questionnaires for patients with IC
deﬁciencies relating to the evaluation of reliability and
measurement error of the VascuQol were identiﬁed.3
Reliability parameters reﬂect the robustness of a mea-
surement instrument, which is particularly relevant in
diagnostic and prognostic research.4 In other words, reli-
ability indicates whether two or more measurements in a
patient with an unchanged health status provide more or
less similar scores on a questionnaire. Measurement error
pertains to the precision of the measurement instrument,
that is, the measurement error indicates the magnitude of
the uncertainty around an observed score. Only a precise
measurement instrument can accurately determine changes
in quality of life, both in evaluation research, as in individual
patients.4
Reliability for the English and Dutch VascuQol has been
examined in just two studies, with 17 and 20 patients,
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used in several languages for many years, its measurement
error was never studied in any language.3 The COnsensus
based Standards for the selection of health Measurement
INstruments (COSMIN) checklist, which was compiled in a
Delphi study among international experts in the ﬁeld of
patient reported outcome measures (PROMS), indicates
that at least 50 patients are necessary for good quality
studies on reliability and measurement error.6 Therefore,
the aim of the study was to determine the testeretest
reliability and measurement error of the VascuQol in pa-
tients with IC in a sufﬁcient sample size.
MATERIAL AND METHODS
Patients
The Academic Medical Center Institutional Review Board
exempted the study from complete ethics approval.
Consecutive patients with symptomatic IC due to PAD were
prospectively recruited from the outpatient clinic or
vascular laboratory between October 2013 and April 2014.
Inclusion criteria were ankle brachial pressure index (ABPI)
of 0.90 at rest or a decrease of ABPI after treadmill testing
(speed 3.2 km/h, 10% incline) by 0.15. As reliability in-
dicates whether repeated measurements provide similar
results in patients with an unchanged health status, only
patients who were not scheduled for an intervention within
2 weeks were selected. Baseline data were collected from
patients’ medical charts.VascuQol
The VascuQol was developed by Morgan et al.2 in 2001. It
consists of 25 items in ﬁve domains (pain, symptoms, ac-
tivities, emotional, and social). Each item is rated on a seven
point scale, with 1 representing the worst and 7 the best
score. A sumscore, also ranging from 1 to 7 (worst to best)
is calculated by adding up the score of all items and then
dividing the total by 25. A score per domain can be calcu-
lated similarly. The VascuQol was originally developed in the
English language. A recent review provides an overview of
the few validation studies available.3
All patients completed the ﬁrst VascuQol questionnaire
at the hospital. The second VascuQol questionnaire was to
be completed at home by all patients 1 week later, and
returned by mail. This timeframe was chosen since, due to
the chronic nature of IC, it is unlikely that a patients’ health
status has changed within 1 week. The questionnaire was
self-administered on both occasions. Non-responders were
reminded by telephone after 8 days. As a means to verify
that patients kept to the 1 week interval between
completing the questionnaires, these were checked for
completely identical pairs once they were returned by mail.Imputation of missing items
Since missing items were anticipated and as many VascuQol
questionnaires as possible were to be included, missing
items per domain were imputed if at least 50% of the itemsin that domain were ﬁlled in, with the mean value of the
ﬁlled items in that particular domain.
Analysis
Baseline data and VascuQol scores on the ﬁrst question-
naire were compared for included and excluded patients
using an unpaired t test or ManneWhitney U test for
continuous variables and a Fisher exact test or chi-square
test for categorical variables where appropriate. A
p value < .05 indicated statistical signiﬁcance.
Testeretest reliability was determined on the VascuQol
scores of the two measurements. It was expressed as the
intra-class correlation coefﬁcient (ICC) of absolute agree-
ment based on a two way mixed model with 95% conﬁ-
dence interval (CI). An ICC  .70 indicates excellent test-
retest reliability.4
Measurement error was expressed as a standard error
of measurement (SEM) and was calculated as follows:
SDdifference/O2, where SDdifference is the standard deviation of
the mean change score between the two time points; O2
was used since the questionnaires were ﬁlled in at two
different time points.4
All analyses were done with SPPS 20.0 (IBM Corporation,
New York, NY, USA).
RESULTS
Demographics and risk factors
Seventy-seven patients consented to participate. Four pa-
tients did not meet the inclusion criterion of an
ABPI  0.90. Of the remaining 73 patients, 61 sufﬁciently
completed the VascuQol twice and 12 patients had to be
excluded for only returning the ﬁrst questionnaire. None of
the included patients returned two questionnaires with
identical responses. The demographics and baseline Vas-
cuQol scores of all 73 patients are summarized in Table 1.
There were no signiﬁcant differences in demographics and
VascuQol scores between included and excluded patients.
Missing items
Fifty-three of 3,050 items (25 items  61
questionnaires  2 time points) were missing in all returned
questionnaires. The number of usable questionnaires after
imputation is shown in Table 2. The social domain was
never imputed since it contains only two items and there-
fore the criterion of 50% of the scale ﬁlled can never be
met.
Reliability
Mean scores and ICC for the imputed and not imputed
VascuQol scores are shown in Table 2. The ICC of the
imputed sumscore was 0.91 (95% CI 0.86e0.95), and the
ICC ranged between 0.77 (95% CI 0.64e0.86) and 0.87 (95%
CI 0.79e0.92) for the different domains, reﬂecting excellent
reliability. Moreover, the ICCs for both the imputed and the
not imputed questionnaires were always in the same range,
diverging no more than 0.02 points.
Table 1. Demographics and risk factors of the included and excluded patients.
Demographics and risk factors Included (N ¼ 61) Excluded (N ¼ 14)
Mean age (SD) 67 (9.2) N ¼ 61 63.6 (11.9) N ¼ 14
Male/Female 37 (60.7%)/24 (39.3%) N ¼ 61 7 (50%)/7 (50%) N ¼ 14
BMI (SD) 26.7 (5.0) N ¼ 61 26.6 (2.7) N ¼ 13
Hypertension 41 (67.2%) N ¼ 61 11 (78.6%) N ¼ 14
Statin use 40 (65.6%) N ¼ 61 9 (64.3%) N ¼ 13
Diabetes mellitus 16 (26.2%) N ¼ 61 5 (35.7%) N ¼ 14
Current smoker 24 (39.3%) N ¼ 61 8 (57.1%) N ¼ 14
Ever smoker 54 (88.5%) N ¼ 60 9 (64.3%) N ¼ 13
Cardiovascular disease 26 (42.6%) N ¼ 61 6 (42.9%) N ¼ 13
Walking distance (m, SD) 213.8 (92.4) N ¼ 51 218.9 (87.9) N ¼ 13
ABPI right (SD) 0.78 (0.23) N ¼ 60 0.81 (0.26) N ¼ 14
ABPI right after exercise (SD) 0.55 (0.28) N ¼ 52 0.44 (0.26) N ¼ 13
ABPI left (SD) 0.72 (0.24) N ¼ 60 0.82 (0.19) N ¼ 14
ABPI left after exercise (SD) 0.46 (0.30) N ¼ 52 0.51 (0.25) N ¼ 13
VascuQol sumscore mean score 4.3 (1.1) N ¼ 59 3.8 (1.2) N ¼ 13
VascuQol activity domain mean score 3.8 (1.1) N ¼ 61 3.6 (1.0) N ¼ 14
VascuQol symptom domain mean score 4.7 (1.0) N ¼ 59 4.3 (1.5) N ¼ 14
VascuQol pain domain mean score 4.0 (1.3) N ¼ 60 3.4 (1.4) N ¼ 14
VascuQol emotional domain mean score 4.7 (1.4) N ¼ 60 4.1 (1.4) N ¼ 14
VascuQol social domain mean score 4.8 (1.6) N ¼ 60 4.3 (1.6) N ¼ 13
Note. Data are presented as mean (SD) or number (percentage). ABPI ¼ ankle brachial pressure index.
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The SEM of the imputed VascuQol sumscore was 0.34 and
ranged between 0.44 and 0.76 for the different domains
(Table 2).DISCUSSION
Although the VascuQol is regarded as a validated HRQL in-
strument, data on its reliability were available from only two
studies comprising only 17 and 20 patients,2,5 which are
insufﬁcient sample sizes for reliability studies.6 A larger
sample was included in this study, and excellent testeretest
reliability for the sumscore and the individual domains of the
Dutch VascuQol was found. The ICC of 0.91 (95% CI 0.86e
0.95) for the sumscore is similar to the 0.94 (95% CI not
given) as determined in 17 patients for the original English
version of the VascuQol.2 The ﬁndings are also in line with
the earlier reliability study of the Dutch VascuQol, performed
by Frans et al.,5 except for the ICC for the social domain. The
ICC in that study was 0.47 (95% CI 0.03e0.75), whereas this
study found an ICC of 0.80 (95% CI 0.68e0.88).5 The result is
more precise due to a larger sample size.Table 2. ICC values and measurement error for the summary score an
VascuQol Mean score
ﬁrst time
point (SD)
Mean score
second time
point (SD)
Mean change
score (SD)a
Sumscore 4.3 (1.1) 4.4 (1.2) 0.03 (0.48)
Activity domain 3.8 (1.1) 3.9 (1.3) 0.08 (0.62)
Symptom domain 4.7 (1.0) 4.8 (1.0) 0.06 (0.66)
Pain domain 4.0 (1.3) 4.1 (1.3) 0.12 (0.68)
Emotional domain 4.7 (1.4) 4.7 (1.4) 0.02 (0.83)
Social domain 4.8 (1.6) 4.7 (1.7) 0.14 (1.07)
ICC ¼ intraclass correlation coefﬁcient; N ¼ number of usable set of q
contains only two items and therefore the criterion of 50% of the s
a Paired data analysis.In the present study the lower limit of the 95% CI of the
ICC for both the symptom and the social domain was below
0.7. The symptom domain contains four items, asking how
much a patient has been troubled by cold feet, tired or
weak legs, “pins and needles or numbness”, and sores and
ulcers. These items might be more applicable to patients
with critical limb ischemia than patients with IC. As a result,
claudicants may answer these items more “at random”,
causing a wide conﬁdence interval. It could be worthwhile
to explore this in a qualitative study. The social domain
contains only two items. This could, at least partially, explain
the wide CI for this domain. Furthermore, all items in the
VascuQol have seven response options, which could very
well be too many. Indeed, in a recent study, Nordanstig
et al.7 found through cognitive interviews that many pa-
tients mentioned the abundance of response options. This
may also cause patients to ﬁll items at random, which in-
ﬂuences outcome.
This study is the ﬁrst to determine the measurement
error of the VascuQol, which is an indication of the accuracy
of a measurement instrument. An international group of
experts in the ﬁeld of health status measurement proposedd different domains.
Imputed Not imputed SEM
ICC (95% CI) ICC (95% CI)
0.91 (0.86e0.95) N ¼ 57 0.92 (0.86e0.96) N ¼ 43 0.34
0.86 (0.78e0.92) N ¼ 61 0.86 (0.76e0.91) N ¼ 54 0.44
0.77 (0.64e0.86) N ¼ 59 0.76 (0.63e0.85) N ¼ 58 0.47
0.87 (0.79e0.92) N ¼ 60 0.87 (0.79e0.93) N ¼ 53 0.48
0.83 (0.73e0.89) N ¼ 60 0.85 (0.75e0.91) N ¼ 48 0.59
NA 0.80 (0.68e0.88) N ¼ 58 0.76
uestionnaires; NA ¼ The social domain was never imputed since it
cale ﬁlled can never be met.
Reliability and Measurement Error of the Dutch VascuQol 505judging the magnitude of the SEM by comparing it to the
minimally important difference (MID).8 The MID represents
the smallest change in score on a questionnaire that is
considered relevant by patients.9 It can be applied in lon-
gitudinal studies, for example to compare patients before
and after treatment. When the measurement error is larger
than the MID, it cannot be determined whether a change in
questionnaire score is due to actual change in the patients’
health status (e.g. due to treatment) or due to inaccurate
measurement by the instrument. Two previous studies have
determined the MID for the VascuQol. The ﬁrst was con-
ducted by Nordanstig et al.10 in a population consisting
predominantly (65%) of IC patients and found an MID of
0.58. The second, recently published study determined the
MID in a larger cohort of claudicants and found an MID of
0.87 to show a clinically relevant improvement.11 The fact
that the SEM of 0.34 found for the VascuQol sumscore is
indeed smaller than the aforementioned MID values in-
dicates that clinically relevant changes over time can be
detected, for example, in longitudinal studies or clinical
practice.
The study has limitations. Some 19% of the included
patients did not ﬁll in the VascuQol questionnaire twice.
Unfortunately, this is not unique to the current study. Pre-
vious studies have reported similar response rates and
also suffered from errors in questionnaires that were
returned.11e13 Non-responding might be caused by a lack of
commitment, difﬁculties in understanding the questionnaire
or interfering comorbidities. These issues should always be
anticipated when using questionnaires, both in research
and in clinical practice. While there were no differences in
baseline characteristics and VascuQol scores between pa-
tients who completed the questionnaire twice and those
who did not, it is unclear how this non-responders inﬂuence
the outcomes of the study.
CONCLUSION
The testeretest reliability of the Dutch version of the Vas-
cuQol is excellent, both for the sumscore and for its
different domains. The VascuQol can detect clinically rele-
vant changes since the measurement error is smaller than
the minimally important difference (MID).
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